Key result
Oral water-soluble phosphatidylcholine improves non-HDL cholesterol and triglyceride target achievement versus placebo.
Why the study?
Does oral water-soluble phosphatidylcholine improve non-HDL cholesterol and triglycerides in patients with combined hyperlipidemia?
RCT
Double-blind
Does oral water-soluble phosphatidylcholine improve non-HDL cholesterol and triglycerides in patients with combined hyperlipidemia?
Answers are grounded in this paper and cite their sources.
An innovative oral water-soluble form of phosphatidylcholine is safe and effective in improving lipid profiles in patients with combined hyperlipidemia.
This article discusses the role of phospholipids as a key component of high-density lipoproteins (HDL) involved in the reverse transport of cholesterol from cells with its subsequent excretion from the body. The results of the phospholipidation research on the capacity of HDL cholesterol efflux from macrophages, as well as an assessment of the hypolipidemic and antiatherogenic effects of phospholipids on an atherosclerosis rabbit model at the functional and morphological levels are presented. In phase I clinical trial the safety of the oral administration of the innovative water-soluble pharmaceutical form of phosphatidylcholine in healthy volunteers was proven. In a double-blind, placebo-controlled phase II-III clinical trial in patients with combined hyperlipidemia its efficacy in achieving of the non-HDL cholesterol and triglycerides therapeutic target and safety with long-term oral administration was demonstrated.
No takes yet. Share an insight, caveat, or question.
Маркин et al. (2025) conducted an RCT in Combined hyperlipidemia. Water-soluble pharmaceutical form of phosphatidylcholine vs. Placebo was evaluated on Achieving of the non-HDL cholesterol and triglycerides therapeutic target and safety. Long-term oral administration of a water-soluble pharmaceutical form of phosphatidylcholine demonstrated efficacy in achieving non-HDL cholesterol and triglyceride therapeutic targets versus placebo.
Synapse has enriched 10 related papers. Consider them for comparative context: